Theravance Biopharma (TBPH) Non-Current Assets (2013 - 2026)
Theravance Biopharma's Non-Current Assets came in at $53.11 million for Q2 2026, down 11.1% from $59.74 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma's Non-Current Assets was $67.11 million, down 65.2% from FY2024.
- Non-Current Assets has declined in each of the last three years, though with a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $193.09 million in FY2024 (-22.3%), $248.46 million in FY2023 (-2.2%), $253.94 million in FY2022 (+573.7%) and $37.7 million in FY2021 (+122.3%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q4 2021.
- Year-over-year, Non-Current Assets has declined for 11 consecutive quarters, with an average decline of 43.4% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2022 (growth of 573.7%), and the weakest in Q2 2025 (a decline of 75.4%).
- Business Quant data shows TBPH's Non-Current Assets at $54.68 million (Q1 2026), $67.11 million (Q4 2025) and $60.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 53.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.11 Mn |
| Mar 31, 2026 | 54.68 Mn |
| Dec 31, 2025 | 67.11 Mn |
| Sep 30, 2025 | 60.76 Mn |
| Jun 30, 2025 | 59.74 Mn |
| Mar 31, 2025 | 193.32 Mn |
| Dec 31, 2024 | 193.09 Mn |
| Sep 30, 2024 | 239.63 Mn |
| Jun 30, 2024 | 242.72 Mn |
| Mar 31, 2024 | 247.01 Mn |
| Dec 31, 2023 | 248.46 Mn |
| Sep 30, 2023 | 251.90 Mn |
| Jun 30, 2023 | 254.63 Mn |
| Mar 31, 2023 | 277.21 Mn |
| Dec 31, 2022 | 253.94 Mn |
| Sep 30, 2022 | 251.78 Mn |
| Jun 30, 2022 | 206.03 Mn |
| Mar 31, 2022 | 150.72 Mn |
| Dec 31, 2021 | 37.70 Mn |
| Sep 30, 2021 | 105.94 Mn |
API Access
Theravance Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();